Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas 77030


Purpose:

The study is designed to compare the effects of nebivolol (10, 20, 40mg/day) with another beta blocker, extended-release metoprolol, at a range of doses. Its purpose is to study the mechanism of action of nebivolol on forearm blood flow, nitric oxide availability and other biomarkers.


Criteria:

Inclusion Criteria: - Male or female, ambulatory outpatients 18-79 years old at screening - Minimum 2-year history of Stage I/II hypertension - Qualifying blood pressure criteria for study entry and for randomization - Willing to adhere to the dietary compliance and undergo protocol procedures - Have a lifestyle that will permit him/her to attend all evaluations, including those conducted on consecutive days Exclusion Criteria: - Have any form of secondary hypertension - Have clinically significant respiratory or cardiovascular disease - Presence/history of coronary artery disease or peripheral vascular disease - Have diabetes mellitus, Type I or II - Have a history of hypersensitivity to nebivolol, metoprolol, or any beta-blocker


NCT ID:

NCT00648895


Primary Contact:

Study Director
Tatjana Lukic, MD., M.Sc.
Forest Research Institute, Inc., a Subsidiary of Forest Laboratories, Inc.


Backup Contact:

N/A


Location Contact:

Houston, Texas 77030
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.